The final frame adjustment is the icing on the cake in the dispensing process and can often be a defining moment in the patient journey. That’s why it is so important to get right, writes MURRAY O’BRIEN.
Australian optometrists are not permitted to prescribe oral medication, in contrast to comparative countries where their counterparts have been prescribing them for years. Insight investigates why this is the case in Australia.
Invasive surgery is often a step too far to eliminate vitreous floaters for many, but DR CON MOSHEGOV says an Australian-developed YAG laser therapy is proving to be an ideal first-line option for selected patients.
In 2020, ophthalmology became the first medical field in Australia to secure approval for a gene therapy. The one-off treatment can restore vision in people once resigned to a lifetime of blindness and is expected to pave the way for many more. MYLES HUME analyses the opportunities and challenges posed by ocular gene therapies. Read more
Melbourne company Cylite is putting the final touches on its Hyperparallel-OCT (HP-OCT) ahead of its official launch next month. The company discusses its journey up until this point and the sophistication that sets its technology apart.
Independent optometrists discuss their decision to harmonise the end-to-end patient journey with the latest ophthalmic lens technology from a single manufacturer, and the value it’s creating for their businesses and patients. Read more
A sub-speciality that bridges ophthalmic and plastic surgery and interfaces with brain surgeons, oncologists and dermatologists is a unique vocation with a specific skill set, as RHIANNON BOWMAN discovers. Read more
How a practice approaches patient recalls can determine their success from both a clinical and business perspective. It is also a field that’s ripe for innovation, writes RHIANNON BOWMAN. Read more
Fortunately, few optometry practices have experienced close contact with a COVID-19-positive patient – and the associated rigmarole. My Sydney city practice HineSight Optometrist, however, did have this experience in early May, which triggered a rabbit-hole journey for my business on several fronts.
With the largest network of practices in Australia, ProVision possesses significant buying power. But as CEO STEVEN JOHNSTON explains, it’s doing much more to ensure independent optometry can continue to flourish, especially amid a record trading period.